Clinical Outcomes of the MYNX CONTROLTM Vascular Closure Device ― A Multicenter Clinical Trial in Japan ―
Background: Vascular closure devices have become standard for hemostasis following the transfemoral approach. The MYNX CONTROL Vascular Closure Device is a percutaneous closure system that delivers a biocompatible, polyethylene glycol-based, water-soluble sealant for extravascular hemostasis. This study evaluated the efficacy and safety of the MYNX CONTROL device for femoral artery puncture site hemostasis in Japanese patients.
Authors
- Yoshiharu Higuchi (ORCID: https://orcid.org/0000-0002-1665-3407)
- Yoshimitsu Soga (ORCID: https://orcid.org/0000-0003-1931-5769)
- Osamu Iida
- Daizo Kawasaki (ORCID: https://orcid.org/0000-0002-4413-6773)
- Masahiko Fujihara (ORCID: https://orcid.org/0000-0002-7001-9220)
- Taku Toyoshima (ORCID: https://orcid.org/0000-0003-1590-5227)
- Kenji Andò (ORCID: https://orcid.org/0000-0003-0699-4248)
- Fumiyuki Hayashi
- Toshiaki Mano (ORCID: https://orcid.org/0000-0002-9047-380X)
- Naoki Hayakawa (ORCID: https://orcid.org/0000-0002-4168-2808)
- Akira Miyamoto (ORCID: https://orcid.org/0000-0002-9162-5983)
- Masato Nakamura
Institutions
- Toho University Ohashi Medical Center (JP)
- Osaka Police Hospital (JP)
- Kansai Rosai Hospital (JP)
- Asahi General Hospital (JP)
- Kishiwada Tokushukai Hospital (JP)
- Morinomiya Hospital (JP)
- Kokura Memorial Hospital (JP)
- Takatsuki General Hospital (JP)
Publication Details
- Journal
- Circulation Reports
- Published
- 2026-10-15
- DOI
- https://doi.org/10.1253/circrep.cr-26-0260
- Primary Topic
- Vascular Procedures and Complications
- Type
- article
- Field-Weighted Citation Impact
- 0.00